Background-The use of antihypertensive medication and hypertension control has significantly increased during recent decades in some developed countries, but the impact of improved drug treatment on blood pressure (BP) control in the population is unknown. Methods and Results-Data were taken from 2 surveys representative of the population aged ≥60 years in Spain conducted with the same methodology in 2000 to 2001 and in 2008 to 2010. BP was measured 6×. The first BP reading was discarded, and the average of the remaining 3 to 5 BP readings was taken for analysis. Hypertension prevalence was 68.7% in 2000 to 2001 and 66.0% in 2008 to 2010. Between both time periods there was an improvement in hypertension awareness (63.6%-67.7%), drug treatment among those aware (84.5%-87.5%), and BP control among treated hypertensives (30.3%-42.9%). Overall, BP control among all hypertensives increased from 16.3% to 25.4%. After adjustment for age, sex, education, hypertension duration, smoking, alcohol consumption, body mass index, sedentary behavior, diabetes mellitus, cardiovascular disease, and visits to the physician through logistic regression, ≈7% of the improvement in BP control among all hypertensives was explained by higher hypertension awareness, and 36.2% was explained by a higher treatment rate. Among the treated hypertensives, 22.6% of the progress in BP control was because of the increase in the number of BP medications used in each patient. Conclusions-BP control among the older hypertensive population in Spain has improved from 2000 to 2001 to 2008 to 2010 because of a higher treatment rate and more intense antihypertensive drug treatment. (Circ Cardiovasc Qual Outcomes. 2015;8:67-76.
H ypertension is an important public health challenge because it is highly prevalent in many developed and developing countries. 1, 2 As a result, high blood pressure (BP) is the leading risk factor for global disease burden, accounting for 7.6 million premature deaths and 7% of disability-adjusted life years worldwide. 3 Moreover, in spite of proved benefits of treating hypertension and availability of abundant guidelines for managing hypertension, [4] [5] [6] [7] BP control in the population is only moderate. 2, 4, 5, 7 Several studies have shown that in some countries the prevalence of hypertension has been generally stable and that a significant improvement in hypertension management has occurred during the past few decades. [8] [9] [10] [11] [12] [13] [14] [15] However, some studies have found no recent progress in BP control, 16, 17 and it has been questioned whether a favorable trend is actually occurring in the population. 18 Discrepancies in results among studies might be partly because of the use of different settings and procedures for BP measurement. Appropriate trend analyses require that (1) BP measurement is accurate, including minimizing the office or white-coat effect 19, 20 and (2) the results of clinic-based studies are considered separately from those of population-based research. In fact, participation in clinicbased studies is probably associated with health status and service accessibility, which are in turn related to the likelihood of being diagnosed with hypertension, of receiving drug treatment and achieving BP control. Thus, clinical surveys mainly serve to monitor the effectiveness of BP control in the clinic, and population-based studies are required to assess BP control in the general population.
Although the use of antihypertensive medication and BP control have significantly increased in some countries during recent decades, 9, [11] [12] [13] [14] 21 to our knowledge no attempts have been made to assess the independent impact of healthcare variables that influence BP control (awareness, treatment, and number of medications) on the changes in BP control over time.
We have used 2 comparable national population-based surveys in Spain that included a series of BP measurements taken in relaxed conditions at subjects' home, 22, 23 to get a reliable picture of the clinical epidemiology of hypertension during the first decade of the 21st century. Specifically, we have estimated the independent contribution of awareness, drug treatment, and number of BP medications to the observed trends in the control of hypertension. Because of data availability, we have focused on the older adult population, where hypertension is frequent but BP control is difficult to achieve. [4] [5] [6] [7] 24 
Methods

Study Design and Participants
We have analyzed data from 2 studies conducted with the same methodology. The first one was performed in 2000 to 2001 among 4009 individuals representative of the noninstitutionalized population aged ≥60 years in Spain. 22 The second study was conducted between 2008 and 2010 on a representative sample of 12 948 people aged ≥18 years, 23, 25 which included 3488 individuals aged ≥60 years. Response rate among these older individuals was 70% and 60% in the first and second study, respectively. In both studies, subjects were selected through census-based multistage cluster random sampling. The information was collected by trained observers, through personal interview using structured questionnaires followed by physical examination (BP and anthropometric variables) at subjects' home.
Participants gave written consent and both studies were approved by the clinical research ethics committees of the Hospital Universitario La Paz in Madrid and the Hospital Clínic in Barcelona.
Study Variables
Study participants reported their age, sex, level of education, hypertension duration (time since hypertension diagnosis by a physician), tobacco and alcohol consumption, sedentary behavior, history of diagnosed diabetes mellitus and cardiovascular disease (coronary heart disease and stroke), and use of healthcare services (annual number of any visit to the physician). Sedentary behavior was estimated with a standard questionnaire that asks about the number of hours spent watching television, seated in transportation, reading, listening to the music, or using the computer, over a typical week, and was defined arbitrarily as ≥37 hours/wk (percentile 65th in the 2000-2001 survey and 70th in the 2008-2010 survey).
In both surveys, BP was measured by trained observers using standardized procedures, 19, 26 with validated automatic devices (Omron 706/711 in 2000-2001 and Omron M6 in 2008-2010) and cuffs of 3 sizes according to arm circumference. In each survey, 2 sets of BP readings were obtained separated by a minimum of 90 minutes. In each set, BP was measured 3× at 1-to 2-minute intervals, after resting 3 to 5 minutes in a seated position. The first BP reading was discarded, and the average of the remaining 3 to 5 BP readings was taken for analysis (mean number of BP readings was 4.69 in 2000 and 4.96 in 2010). Hypertension was defined as systolic BP (SBP) ≥140 mm Hg and diastolic BP ≥90 mm Hg and on current antihypertensive drug treatment. Hypertension awareness was deemed as an affirmative answer to the question: Have you ever been told by the doctor that you had hypertension? Treatment was defined as reported current use of prescribed hypertension drug therapy. Finally, BP control was defined as pharmacological treatment of hypertension associated with SBP <140 mm Hg and diastolic BP <90 mm Hg, which were the BP goals at the time of the surveys analyzed.
Weight and height were measured in each subject under standardized conditions. 25 Body mass index (BMI) was calculated as weight in kilograms divided by squared height in meter. Obesity was defined as BMI ≥30 kg/m 2 .
Medication use was collected by a face-to-face interview and verified against drug packaging during the home visit in both surveys. Antihypertensive medications were classified according to the international guidelines. 26 Main independent variables were T, sociodemographic characteristics, cardiovascular risk factors, and use of healthcare services, which might be relevant for hypertension control 4-7 and were selected a priori. The sociodemographic characteristics included age, sex, and educational level, whereas the cardiovascular risk factors included hypertension duration, BMI, sedentary behavior, smoking, alcohol consumption, diabetes mellitus, and cardiovascular disease. The odds ratio (OR) of T measures whether BP control has improved between both surveys after adjusting for those characteristics. Healthcare variables influencing BP control (awareness, drug treatment, and number of BP medications) were added sequentially to the models. Specifically, the first model, run on 4076 hypertensives (88.2% of all the hypertensive patients), was additionally adjusted for hypertension awareness and antihypertensive drug treatment; and the second model, run on 2264 treated hypertensives (87.1% of the treated hypertensive patients), was additionally adjusted for the number of BP medications because all patients were aware and treated. The change
Statistical Analysis
WHAT IS KNOWN
• The use of antihypertensive medication as well as hypertension control has significantly increased during recent decades in some developed countries, but the impact of improved drug treatment on hypertension control has not been assessed.
WHAT THE STUDY ADDS
• Blood pressure control among hypertensive patients aged ≥60 years in Spain has improved from 2000 to 2001 to 2008 to 2010. • One third of this progress is explained by higher drug treatment rates beyond what is explained by sociodemographic variables, cardiovascular risk factors, and hypertension awareness. Among treated hypertensives, 23% of the progress in blood pressure control was because of the greater number of blood pressure medications used in each patient. • These findings remark the importance of a higher and more intense use of drug treatments for achieving hypertension control in the general population.
in the OR of T measures the independent contribution of each of these healthcare variables to the change in hypertension control between the 2 surveys and was calculated using the formula: [OR (fully adjusted except for the specific healthcare variable) -OR (fully adjusted model) ]×100/[OR (fully adjusted except for the specific healthcare variable) -1]. 27 Variables were modeled as categorical (dichotomic) except age, hypertension duration, BMI, and number of BP medications (continuous). The analyses were conducted in the total study sample and separately by sex. Statistical significance was set at 2-sided P<0.05. Analyses were performed with the SPSS package v. 21.0.
Results
Change in Hypertension Prevalence
The prevalence of hypertension decreased from 68.7% in 2000 to 2001 to 66.0% in 2008 to 2010 (Table 1 ).This reduction occurred specifically among individuals aged <80 years, women, with lower education, and absence of diabetes mellitus or obesity.
Change in Hypertension Awareness, Treatment, and Control
Awareness of hypertension and drug treatment among the aware hypertensives increased slightly between 2000 to 2001 and 2008 to 2010 (63.6%-67.7% and 84.5%-87.5%, respectively; Table 2 ). Thus, drug treatment among all hypertensive patients increased from 53.7% in 2000 to 2001 to 59.2% in 2008 to 2010. Moreover, a substantial improvement in BP control was found among treated hypertensives (30.3%-42.9%). The improvement in awareness and drug treatment was greater in persons aged ≥70 years, men, with lower education, with diabetes mellitus or obesity, and without sedentary behavior. However, the improvement in BP control among treated hypertensives was more frequent among patients aged <80 years, men, with higher education, without obesity, or sedentary behavior ( Table 2) . Overall, BP control among all hypertensive patients increased from 16.3% in 2000 to 2001 to 25.4% in 2008 to 2010, an improvement that was higher in patients aged <80 years, men, with higher education, diabetes mellitus, without obesity or sedentary behavior, and in those on <3 drugs (Table 3) . Table 4 shows the time changes in variables which could potentially influence the change in BP control among hypertensive patients. Mean age was somewhat lower in 2008 to 2010 than in 2000 to 2001 (69.9 and 72.1 years, respectively).
Factors Contributing to Change in BP Control
The percentage of hypertensives with ≤primary education fell from 87.7% to 60.0%. Both mean SBP and mean diastolic BP decreased significantly (2.9 and 1.7 mm Hg, respectively). Moreover, sedentary behavior became less frequent, and a significant reduction was seen in the frequency of previous cardiovascular disease. The percentage of current smokers increased slightly (among women) as well as the percentage of current alcohol drinkers. Finally, the number of antihypertensive drugs increased between 2000 to 2001 and 2008 to 2010 (1.4-1.8), and the percentage on combination therapy increased from 40.9% to 48.6% relying heavily on those on ≥3 medications (9.6%-15.6%). Logistic regression analyses show that the odds of BP control among all hypertensive patients was 1.75× greater in 2008 to 2010 than in 2000 to 2001, and it was still 1.74× higher after adjusting for sociodemographic variables, cardiovascular risk factors, and use of healthcare services (Table 5 ). That is, a real improvement in BP control has occurred between both time periods, regardless of those important BP-related variables. After additional adjustment for hypertension awareness, the OR was 1.69; in relative terms, a 6.8% lower than before adjustment. Thus, awareness of hypertension contributed, although to a moderate extent, to the increase in BP control over time. Finally, additional adjustment for antihypertensive drug treatment used yielded an OR of 1.44. Thus, 36.2% of the improvement in BP control was explained by drug treatment beyond what is explained by awareness and the rest of variables (Table 5 ). Taken together, awareness and treatment explained 40.5% of the change observed in BP control. Separate models for men and women showed that the contribution of hypertension awareness and drug treatment to the improvement in BP control was higher among women ( Table 5) .
Among treated hypertensive patients, the OR of BP control was 1.62 after adjusting for sociodemographic and clinical variables (Table 6) ; additional adjusted for the number of BP medications led to and OR of 1.48. Thus, the increase in the number of BP medications between 2000 to 2001 and 2008 to 2010 explained 22.6% of the improvement in BP control, beyond what was accounted for sociodemographic and clinical variables. The influence of the number of antihypertensive drugs was somewhat higher among women (23.6% versus 19.0% in men).
Discussion
To our knowledge, this is the first study to systematically examine the impact of hypertension awareness and treatment on the time trends in BP control among older hypertensive patients from the general population. Our results show that the degree of BP control in hypertensive individuals improved significantly from 2000 to 2001 to 2008 to 2010, and that a substantial part of the improvement was because of a greater treatment rate and to an increase in the number of BP medications used in each patient.
Comparison With Other Studies
Previous reports in many countries have shown a high prevalence of hypertension, particularly in older age groups, and generally stable or modest reductions in hypertension prevalence in the past few decades. 2, [8] [9] [10] [11] [12] [13] [14] 16 In our study, both the prevalence and the mean SBP and diastolic BP fell over time, which is consistent with a recent pooled analysis showing a worldwide reduction in SBP since 1980. 28 The decrease in the prevalence of hypertension in Spain occurred selectively among women, probably related to the reduction in BMI recently observed in older women but not in older men. 29 As in most other countries, awareness, treatment, and control of hypertension have generally increased in hypertensive patients, although the success rates achieved varied by country and sociodemographic and clinical subgroups.. 9, [11] [12] [13] [14] [15] Control of hypertension among treated hypertensive patients improved by 13% in absolute terms (from 30% in 2000-2001 to 43% in 2008-2010). However, hypertension control is still far from the rates in a few other countries, such as England (41% in 2003 and 50% in 2006 for treated hypertensive patients ≥65 years), 9 aged >60 years) and especially, Canada, where the control rate among treated patients was 64% in 2009. 12, 13, 16 Nevertheless, hypertension control among both those treated and all hypertensives in Spain was comparable with or even higher than in many other countries. 10, 11, 14, 15, 30 
Explanations for Changes in Hypertension Control
This study confirms the important role of drug treatment in BP control [4] [5] [6] [7] and extends previous reports by quantifying the impact of increased awareness, treatment, and the number of BP medications. The higher contribution of awareness and treatment of hypertension to the improvement in BP control over time among women than men is consistent with their more favorable trend in SBP (absolute change, −3.7 versus −2.1 mm Hg in men), sedentary behavior (−12% versus −1%), diabetes mellitus (-3.6% versus +2.1%), and combined therapy (+8.8% versus +5.9%). There is also evidence in some countries of a significant increase in the proportion of hypertensives taking multiple antihypertensive agents, 9, 21, 31, 32 in consonance with guidelines indicating that ≥2 antihypertensive agents are usually needed to achieve BP goals. [4] [5] [6] [7] However, no previous quantification of the impact of medication on time changes in BP control has been made. Interestingly, the greater increase in polytherapy among hypertensive patients aged ≥60 years in the United States 21 than in Spain during approximately the same time period (44.5% in 2000-2001 to 56.1% in 2009-2010 versus 40.9% to 48.6%, respectively) was accompanied by a higher increase in BP control among treated patients in the United States (37.5%-55.8%) than in Spain (30.3%-42.9%).
Intensification of drug treatment has been associated with a reduction of cardiovascular risk in habitual clinical practice. 33 However, in Spain and the United States, physicians failed to increase medications in most uncontrolled hypertensive patients, especially in the elderly. 34, 35 Reluctance to initiate combination therapy in older patients was often because of safety concerns such as orthostatic hypotension. [4] [5] [6] [7] Also, as reported in the United States, 32 we found that the proportion of treated uncontrolled patients taking 1 to 2 medications (a proxy for treatment inertia in our study) fell from 89.3% in 2000 to 2001to 81.9% in 2008 to 2010, and the proportion on ≥3 medications (a proxy for apparent treatment-resistant hypertension) rose from 10.6% in 2000 to 18.1% in 2010 (data not presented).
Overall, we were able to identify factors that accounted for <50% of the improvement in BP control in Spain during the past decade. The remainder, however, should still be elucidated. We have no data on trends in the salt content in food or sodium excreted in urine over time, but as in other countries, 36 high levels are observed currently in Spain. 37 Moreover, the diet of hypertensive patients in Spain, including older individuals, has a low accordance with the Dietary Approaches to Stop Hypertension (DASH) and Mediterranean dietary pattern, including sodium intake, 37 which may be counterbalancing efforts in drug treatment. Also, we did not study the potential effect of trends in advice and adherence to healthy lifestyle on BP control.
Methodological Aspects
Although the response rate in the Spanish surveys was somewhat lower than in the NHANES surveys in the United States, 38 it was among the highest of the examination surveys conducted in Europe. 9, 39 Moreover, the sex, age, and educational level structure of the national surveys closely resemble the sociodemographic distribution of the Spanish population. 22, 25 As regards variable measurement, 6 BP readings were made by trained lay personnel at subjects' household, and the first measurement was excluded for analysis; all these contribute to reducing the alerting reaction. Also, the increase in BP control in Spain in the past decade was consistent with that reported in a series of primary-care surveys across the country. 31 In addition, medication packages were checked at subjects' home, which contributes to the accuracy of data in drug treatment. Unfortunately, medication dose and adherence were not assessed.
We made an additional sensitivity analysis using the recently proposed clinic BP goal of 150/90 mm Hg for older people. 40 As expected, BP control among treated hypertensives was much better when using the 150/90 threshold in both time periods (49.7% in 2000 and 63.9% in 2010). Also, the percentage contribution of the number of BP medications to the improvement in BP control between 2000 and 2010 was 15.9% (versus 22.6% using the 140/90 threshold). Thus, proportions of hypertension control and contribution of the number of BP medications were sensitive to the BP threshold, although the message of progress in BP control and the importance of more intense use of drug treatment remain.
The proportions of prevalence and management of hypertension were presented stratified by age and clinical characteristics rather than adjusted; nevertheless, age-adjusted proportions remained similar (data not shown).
Given that the number of missing data for univariate and multivariable analyses was not high (<10% and <15%, respectively), and that there were no significant differences between persons with missing data and those without for most important variables (data not shown), we think bias because of excluded cases should not be relevant. However, there still may be bias because of unmeasured factors. About the multivariable analyses, we adjusted for BP-related lifestyles and other important cardiovascular risk factors, thus isolating to some extent the independent effect of drug treatment on changes in BP control. Finally, the extrapolation to other countries with higher or lower values of the variables studied should be done with caution. Nevertheless, there is no reason to doubt that the same Logistic regression models were progressively adjusted for sociodemographic variables (age, sex, and education level), cardiovascular risk factors (hypertension duration, body mass index, sedentariness, diabetes mellitus, tobacco smoking, alcohol consumption, and cardiovascular disease), use of healthcare services (physicians annual visits), hypertension awareness, and antihypertensive drug treatment. Year 2000 to 2001 was used as the reference category (odds ratio, 1).
*Percentage contribution of the specific healthcare variables (awareness and treatment) to the change in hypertension control between the 2 time periods, after adjustment for the rest of the above variables (for calculation, see the Methods section of this article). factors are influencing trends in different countries, although the relative contribution of each one could vary.
Conclusions and Implications
Among older adults in Spain, BP control has increased during the past decade, and it was partly because of higher treatment rates and more intense drug treatment. However, despite progress, in 2008 to 2010 about one third of hypertensive patients were still unaware of their hypertensive status, 40% were untreated, and more than half of treated patients were uncontrolled; as a result, only 1 in 4 patients achieved BP targets. Our results remark the importance of renewed efforts aiming at even higher and more intense use of drug treatments for achieving hypertension control in the general older population.
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